Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-cash Items (2019 - 2025)

Historic Non-cash Items for Inmune Bio (INMB) over the last 7 years, with Q3 2025 value amounting to $5.4 million.

  • Inmune Bio's Non-cash Items rose 687.82% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 687.82%. This contributed to the annual value of $1.2 million for FY2024, which is 9433.73% down from last year.
  • Latest data reveals that Inmune Bio reported Non-cash Items of $5.4 million as of Q3 2025, which was up 687.82% from $5.4 million recorded in Q2 2025.
  • Inmune Bio's Non-cash Items' 5-year high stood at $40.6 million during Q2 2021, with a 5-year trough of $1.2 million in Q4 2024.
  • In the last 5 years, Inmune Bio's Non-cash Items had a median value of $7.9 million in 2023 and averaged $11.0 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 159881.68% in 2021, then crashed by 9433.73% in 2024.
  • Quarter analysis of 5 years shows Inmune Bio's Non-cash Items stood at $11.2 million in 2021, then rose by 16.09% to $13.0 million in 2022, then skyrocketed by 65.45% to $21.5 million in 2023, then tumbled by 94.34% to $1.2 million in 2024, then soared by 341.63% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $5.4 million for Q2 2025, and $5.1 million during Q1 2025.